HFML-FELIX research featured in "Medisch Contact"
Date of news: 7 July 2021
Researchers from HFML-FELX and the Translational Metabolic Laboratory of the Radboudumc have discovered biomarkers that can be used to detect the metabolic disease pyridoxine-dependent epilepsy (PDE) in neonatal screening (the newborn heel prick).
Their work, published in the Journal of Clinical Investigation, has been published as a scientific highlight in Medisch Contact, thé professional journal for doctors and those working in and around healthcare in the Netherlands.